Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
  2. 8-K Event Executive or director change
  3. 10-K Report Annual Report
  4. 8-K Event Executive or director change
  5. 8-K Event Results of operations · Exit or restructuring costs · Other events
  6. 8-K Event Material agreement · Executive or director change
  7. 8-K Event Delisting notice
  8. 8-K Event Executive or director change
  9. 8-K Event Results of operations · Bylaws or fiscal year change · Other events
  10. 8-K Event Executive or director change
  11. 8-K Event Material agreement · New debt or obligation · Executive or director change · Shareholder vote results
  12. 8-K Event Acquisition or sale completed · Executive or director change
  13. 8-K Event Material agreement · Results of operations · Unregistered share sale · Executive or director change
  14. 8-K Event Other events
  15. 8-K Event Exit or restructuring costs · Executive or director change
  16. DEF 14A Proxy Proxy Statement
  17. 8-K Event Executive or director change
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Other events
  20. 8-K Event Other events

Page 4 of 5 · 100 filings